Novavax, Inc (NASDAQ: NVAX) Hogging The Spotlight Today
Currently, there are 160.19M common shares owned by the public and among those 153.02M shares have been available to trade. The company’s stock has a 5-day price change of -13.10% and -39.86% over the past three months. NVAX shares are trading 63.12% year to date (YTD), with the 12-month market performance up to 34.31% higher. […]
Novavax, Inc (NASDAQ: NVAX) Hogging The Spotlight Today
Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of -1.21% and -25.90% over the past three months. NVAX shares are trading 87.71% year to date (YTD), with the 12-month market performance up to 34.28% higher. […]
Are Analysts Expecting A Better 2020 For Novavax, Inc (NVAX)?
Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $8.96, with 6.36 million shares of worth about $57.03 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 100.45% during that period and on November 06, 2024 the price saw a loss […]
Novavax, Inc. (NASDAQ: NVAX): Stock That Needs Special Handling
Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of -0.49% and -21.39% over the past three months. NVAX shares are trading 109.79% year to date (YTD), with the 12-month market performance up to 58.58% higher. […]
An Important Check-Up On Novavax, Inc. (NASDAQ: NVAX)
Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $10.00, with 3.33 million shares of worth about $33.34 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 140.96% during that period and on October 23, 2024 the price saw a loss […]
Novavax, Inc. (NASDAQ: NVAX): The Best-Of-Breed For Investing?
Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of -3.07% and -23.24% over the past three months. NVAX shares are trading 162.92% year to date (YTD), with the 12-month market performance up to 69.40% higher. […]
Institutional Exposure To Novavax, Inc. (NVAX)
Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $12.68, with 6.04 million shares of worth about $76.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 197.65% during that period and on October 09, 2024 the price saw a loss […]
Is Novavax, Inc. (NASDAQ: NVAX) Back In The Buying Zone?
Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of -7.30% and -5.01% over the past three months. NVAX shares are trading 156.67% year to date (YTD), with the 12-month market performance up to 70.17% higher. […]
Do Novavax, Inc. (NASDAQ: NVAX) Fit In A Value Investing Philosophy?
Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of 2.78% and -5.07% over the past three months. NVAX shares are trading 176.87% year to date (YTD), with the 12-month market performance up to 86.40% higher. […]
Novavax, Inc. (NASDAQ: NVAX) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]
